|Dr. Richard A. B. Stewart||Chairman & CEO||772.64k||N/A||1959|
|Dr. Anthony Clarke||Pres, Chief Scientific Officer & Director||603.22k||N/A||1956|
|Mr. John A. Bencich||Exec. VP, CFO & COO||539.31k||N/A||1977|
|Dr. Cindy Jacobs||Exec. VP & Chief Medical Officer||593.5k||N/A||1958|
|Ms. Jaime Xinos||Exec. VP of Commercial||N/A||N/A||N/A|
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. The company is based in Vancouver, Canada.
Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.